Format

Send to

Choose Destination
Biochem Biophys Res Commun. 2010 Apr 30;395(2):232-7. doi: 10.1016/j.bbrc.2010.03.169. Epub 2010 Mar 31.

GPR35 is a novel lysophosphatidic acid receptor.

Author information

1
Teikyo University, Sagamihara, Kanagawa 252-5195, Japan.

Abstract

GPR35 is a rhodopsin-like G protein-coupled receptor identified in 1998. It has been reported that kynurenic acid, a tryptophan metabolite, may act as an endogenous ligand for GPR35. However, the concentrations of kynurenic acid required to elicit the cellular responses are usually high, raising the possibility that another endogenous ligand may exist. In this study, we searched for another endogenous ligand for GPR35. Finally, we found that the magnitude of the Ca(2+) response induced by 2-acyl lysophosphatidic acid in the GPR35-expressing HEK293 cells was markedly greater than that in the vector-transfected control cells. Such a difference was not apparent in the case of 1-acyl lysophosphatidic acid. 2-Acyl lysophosphatidic acid also caused the sustained activation of RhoA and the phosphorylation of extracellular signal-regulated kinase, and triggered the internalization of the GPR35 molecule. These results strongly suggest that 2-acyl lysophosphatidic acid is an endogenous ligand for GPR35.

PMID:
20361937
DOI:
10.1016/j.bbrc.2010.03.169
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center